Nuvation Bio (NUVB)
(Delayed Data from NYSE)
$3.22 USD
+0.02 (0.63%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $3.21 -0.01 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Nuvation Bio Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -75.80 | -104.20 | -86.85 | -3.05 | NA |
Depreciation/Amortization & Depletion | 0.22 | 0.20 | 0.18 | 0.00 | NA |
Net Change from Assets/Liabilities | 0.54 | -3.45 | 4.79 | 2.36 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 7.04 | 11.34 | 13.68 | -0.01 | NA |
Net Cash From Operating Activities | -68.00 | -96.11 | -68.19 | -0.70 | NA |
Property & Equipment | -0.06 | -0.36 | -0.28 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 8.98 | 63.81 | -454.39 | -143.75 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | 8.92 | 63.46 | -454.67 | -143.75 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.63 | 1.33 | 0.76 | 145.75 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | 0.00 | 624.77 | -0.39 | NA |
Net Cash from Financing Activities | 0.63 | 1.33 | 625.53 | 145.36 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -58.45 | -31.32 | 102.67 | 0.91 | NA |
Cash at Beginning of Period | 101.10 | 132.42 | 29.76 | 0.00 | NA |
Cash at End of Period | 42.65 | 101.10 | 132.42 | 0.91 | NA |
Diluted Net EPS | -0.35 | -0.48 | -0.44 | -0.80 | NA |
Fiscal Year End for Nuvation Bio Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -477.28 | -14.79 | -75.80 | -62.02 | -42.37 |
Depreciation/Amortization & Depletion | 0.30 | 0.06 | 0.22 | 0.17 | 0.11 |
Net Change from Assets/Liabilities | -10.73 | -4.61 | 0.54 | 1.98 | 0.15 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 434.69 | 3.64 | 7.04 | 6.90 | 5.29 |
Net Cash From Operating Activities | -53.03 | -15.70 | -68.00 | -52.97 | -36.82 |
Property & Equipment | -0.03 | -0.03 | -0.06 | -0.06 | -0.03 |
Acquisition/ Disposition of Subsidiaries | 19.86 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 29.32 | 7.57 | 8.98 | -24.19 | -14.62 |
Other Investing Activities | -7.34 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 41.82 | 7.54 | 8.92 | -24.24 | -14.65 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.06 | 0.02 | 0.63 | 0.51 | 0.43 |
Issuance (Repayment) of Debt | 0.71 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 2.77 | 0.02 | 0.63 | 0.51 | 0.43 |
Effect of Exchange Rate Changes | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -8.36 | -8.14 | -58.45 | -76.70 | -51.03 |
Cash at Beginning of Period | 42.65 | 42.65 | 101.10 | 101.10 | 101.10 |
Cash at End of Period | 34.29 | 34.51 | 42.65 | 24.40 | 50.07 |
Diluted Net EPS | -1.89 | -0.07 | -0.07 | -0.09 | -0.09 |